Ajanta Pharma Ltd, headquartered in Mumbai, India, is a leading specialty pharmaceutical company focused on the development, manufacturing, and marketing of high-quality medicines. Established in 1973, the company operates in over 30 countries, with a strong presence in India, Asia, Africa, the Middle East, and the USA. Ajanta Pharma specializes in key therapeutic segments such as Cardiology, Ophthalmology, Dermatology, Pain Management, and Anti-Malarial. The company has seven state-of-the-art manufacturing facilities, approved by USFDA, WHO, and other global regulatory bodies. Known for its innovation-driven approach, Ajanta invests significantly in R&D, developing differentiated and niche pharmaceutical products. The company has a growing portfolio of ANDA filings in the U.S. and continues to expand its presence in regulated and emerging markets. With a commitment to quality, compliance, and sustainability, Ajanta Pharma continues to drive profitable growth and improve access to healthcare worldwide.